These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6317554)

  • 21. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects.
    Laubie M; Schiavi P; Vincent M; Schmitt H
    J Cardiovasc Pharmacol; 1984; 6(6):1076-82. PubMed ID: 6084763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentiation of the actions of bradykinin by angiotensin I-converting enzyme inhibitors. The role of expressed human bradykinin B2 receptors and angiotensin I-converting enzyme in CHO cells.
    Minshall RD; Tan F; Nakamura F; Rabito SF; Becker RP; Marcic B; Erdös EG
    Circ Res; 1997 Nov; 81(5):848-56. PubMed ID: 9351459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models.
    Nagata S; Takeyama K; Fukuya F; Nagai R; Hosoki K; Nishimura K; Deguchi T; Karasawa T
    Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypotensive effect of bradykinin in normotensives and patients with renovascular hypertension.
    Bönner G; Schunk U
    Adv Exp Med Biol; 1986; 198 Pt B():321-7. PubMed ID: 3544729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of kinins in the acute antihypertensive effect of enalapril in hypertensive rats.
    Salgado MC; Name CF
    Braz J Med Biol Res; 1994 Jun; 27(6):1391-401. PubMed ID: 7894353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibition.
    Van Guilder GP; Pretorius M; Luther JM; Byrd JB; Hill K; Gainer JV; Brown NJ
    Hypertension; 2008 Feb; 51(2):454-9. PubMed ID: 18180402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin-converting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykinin.
    Pretorius M; Rosenbaum D; Vaughan DE; Brown NJ
    Circulation; 2003 Feb; 107(4):579-85. PubMed ID: 12566370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.
    Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC
    J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of angiotensin converting enzyme by (R)-3-[(S)-1-carboxy-5-(4-piperidyl)pentyl]amino-4-oxo-2,3,4,5-tetra- hydro-1,5-benzothiazepine-6-acetic acid (CV-5975), a non-sulfhydryl compound.
    Inada Y; Tanabe M; Itoh K; Sugihara H; Nishikawa K
    Jpn J Pharmacol; 1988 Nov; 48(3):323-30. PubMed ID: 2851678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Relationship between the kininase and angiotensin-converting lung functions in rabbits with cerebroischemic and renovascular hypertension].
    Karpitskiĭ VV; Gomazkov OA
    Biull Eksp Biol Med; 1982 Jan; 93(1):24-6. PubMed ID: 6279206
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of pH on the inhibition of angiotensin converting activity by enalaprilat in the rat perfused mesenteric vascular bed.
    Lindsey CJ; Bendhack LM; Paiva AC
    J Pharmacol Exp Ther; 1987 Oct; 243(1):292-6. PubMed ID: 2822902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
    Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K
    Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue kallikrein-kinin system in the brain and the regulation of arterial pressure.
    Fior DR; Martins DT; Lindsey CJ
    Agents Actions Suppl; 1992; 38 ( Pt 3)():31-8. PubMed ID: 1334357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of angiotesin-converting enzyme by quercetin alters the vascular response to brandykinin and angiotensin I.
    Häckl LP; Cuttle G; Dovichi SS; Lima-Landman MT; Nicolau M
    Pharmacology; 2002 Aug; 65(4):182-6. PubMed ID: 12174832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of angiotensin-(1-7) in the modulation of the baroreflex in renovascular hypertensive rats.
    Britto RR; Santos RA; Fagundes-Moura CR; Khosla MC; Campagnole-Santos MJ
    Hypertension; 1997 Sep; 30(3 Pt 2):549-56. PubMed ID: 9322980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for bradykinin potentiation by angiotensin congeners in conscious rats.
    Textor SC; Brunner H; Gavras H
    Am J Physiol; 1981 Feb; 240(2):H255-61. PubMed ID: 6258451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of PGI2 and effects of ACE inhibition on the bradykinin potentiation by angiotensin-(1-7) in resistance vessels of SHR.
    Fernandes L; Fortes ZB; Casarini DE; Nigro D; Tostes RC; Santos RA; de Carvalho MH
    Regul Pept; 2005 Apr; 127(1-3):183-9. PubMed ID: 15680485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic infusion of lisinopril into hypothalamic paraventricular nucleus modulates cytokines and attenuates oxidative stress in rostral ventrolateral medulla in hypertension.
    Li HB; Qin DN; Ma L; Miao YW; Zhang DM; Lu Y; Song XA; Zhu GQ; Kang YM
    Toxicol Appl Pharmacol; 2014 Sep; 279(2):141-9. PubMed ID: 24937322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentiation of bradykinin by angiotensin-(1-7) on arterioles of spontaneously hypertensive rats studied in vivo.
    Fernandes L; Fortes ZB; Nigro D; Tostes RC; Santos RA; Catelli De Carvalho MH
    Hypertension; 2001 Feb; 37(2 Pt 2):703-9. PubMed ID: 11230360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CI-906 and CI-907: new orally active nonsulfhydryl angiotensin-converting enzyme inhibitors.
    Kaplan HR; Cohen DM; Essenburg AD; Major TC; Mertz TE; Ryan MJ
    Fed Proc; 1984 Apr; 43(5):1326-9. PubMed ID: 6323223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.